Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression

Acta Biomaterialia - Tập 5 Số 4 - Trang 1284-1293 - 2009
Junying Sun1, Wei Li1, Xuanyong Liu2, Jianyou Li1, Baoe Li2, Guocheng Wang2, Fanhao Meng2
1Orthopedic Department, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, Jiangsu 215006, People’s Republic of China
2Shanghai Institute of Ceramics, Chinese Academy of Sciences, 1295 Dingxi Road, Shanghai 200050, People's Republic of China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Webster, 2001, 125, 10.1016/S0065-2377(01)27005-7

Vercaigne, 1998, The effect of titanium plasma sprayed implants on trabecular bone healing in the goat, Biomaterials, 19, 1093, 10.1016/S0142-9612(98)00039-8

Lynn, 2002, Hydroxyapatite-coated Ti–6Al–4V part 2: the effects of post-deposition heat treatment at low temperatures, Biomaterials, 23, 1947, 10.1016/S0142-9612(01)00320-9

Bloebaum, 1994, Complications with hydroxyapatite particulate separation in total hip arthroplasty, Clin Orthop, 298, 19, 10.1097/00003086-199401000-00005

Dalton, 1995, In vivo mechanical and histological characteristics of HA-coated implants vary with coating vendor, J Biomed Mater Res, 29, 239, 10.1002/jbm.820290215

Sun, 1999, The influence of hydroxyapatite particles on osteoclast cell activities, J Biomed Mater Res, 45, 311, 10.1002/(SICI)1097-4636(19990615)45:4<311::AID-JBM5>3.0.CO;2-9

Yang, 2003, Mechanical properties and Young’s modulus of plasma-sprayed hydroxyapatite coating on Ti substrate in simulated body fluid, J Biomed Mater Res, 67A, 886, 10.1002/jbm.a.10145

Suchanek, 1998, Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants, J Mater Res, 13, 94, 10.1557/JMR.1998.0015

Salinas, 2001, Biomimetic apatite deposition on calcium silicate gel glasses, J Sol–gel Sci Technol, 21, 13, 10.1023/A:1011249330581

Xie, 2005, Bioactive titanium-particle-containing dicalcium silicate coating, Surf Coat Technol, 200, 1950, 10.1016/j.surfcoat.2005.08.070

Oonishi, 2000, Quantitative comparison of bone growth behavior in granules of bioglass, A–W glass–ceramic, and hydroxyapatite, J Biomed Mater Res, 51, 37, 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T

Kokubo, 1990, Surface chemistry of bioactive glass–ceramics, J Non-Cryst Solids, 120, 138, 10.1016/0022-3093(90)90199-V

Liu, 2005, Early apatite deposition and osteoblasts growth on plasma sprayed dicalcium silicate coating, J Biomed Mater Res, 74A, 356, 10.1002/jbm.a.30273

Gough, 2004, Nodule formation and mineralization of human primary osteoblasts cultured on a porous bioactive glass scaffold, Biomaterials, 25, 2039, 10.1016/j.biomaterials.2003.07.001

Chang, 2000, Calcium and phosphate supplementation promotes bone cell mineralization: implications for hydroxyapatite (HA)-enhanced bone formation, J Biomed Mater Res, 52, 270, 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1

Ralstion, 1994, Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase, Endocrinology, 135, 330, 10.1210/en.135.1.330

Spinella-jaegle, 2001, Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation, Bone, 29, 323, 10.1016/S8756-3282(01)00580-4

Borsari, 2005, Comparative in vitro study on a ultra-high roughness and dense titanium coating, Biomaterials, 26, 4948, 10.1016/j.biomaterials.2005.01.010

Christodoulou, 2006, Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel–glass ionic dissolution products, J Biomed Mater Res B: Appl Biomater, 77B, 431, 10.1002/jbm.b.30455

Xynos, 2001, Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution, J Biomed Mater Res, 55, 151, 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D

Reffitt, 2003, Orthosilicic acid stimulates collagen 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro, Bone, 32, 127, 10.1016/S8756-3282(02)00950-X

Hench, 1988, Bioactive ceramics, Ann NY Acad Sci, 523, 54, 10.1111/j.1749-6632.1988.tb38500.x

Sepulveda, 2001, In vitro dissolution of melt-derived 45S5 and sol–gel derived 58S bioactive glasses, J Biomed Mater Res, 61, 301, 10.1002/jbm.10207

Choi, 2001, Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development, Proc Natl Acad Sci USA, 98, 8650, 10.1073/pnas.151236498

Pratap, 2003, Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts, Cancer Res, 63, 5357

Boanini, 2006, Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells, Biomaterials, 27, 4428, 10.1016/j.biomaterials.2006.04.019

Tsuji, 2006, BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing, Nat Genet, 38, 1424, 10.1038/ng1916

Piek, 1999, Specificity, diversity, and regulation in TGF-β superfamily signaling, FASEB J, 13, 2105, 10.1096/fasebj.13.15.2105

Wrana, 2000, Regulation of Smad activity, Cell, 100, 189, 10.1016/S0092-8674(00)81556-1

Miyazono, 2000, TGF-β signaling by Smad proteins, Cytok Growth Factor Rev, 11, 15, 10.1016/S1359-6101(99)00025-8

Keeting, 1992, Zeolite A increases proliferation, differentiation, and transforming factor β production in normal adult osteoblast-like cells in vitro, J Bone Miner Res, 7, 1281, 10.1002/jbmr.5650071107

Gao, 2001, Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro, Biomaterials, 22, 1475, 10.1016/S0142-9612(00)00288-X

Bergeron, 2007, Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres, J Mater Sci: Mater Med, 18, 255, 10.1007/s10856-006-0687-4

Clarke, 2007, Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX™, in association with autologous osteogenic cells and growth factors, Bone, 40, 939, 10.1016/j.bone.2006.11.004

Kruyt, 2007, Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats, Biomaterials, 28, 1798, 10.1016/j.biomaterials.2006.11.038

Sachse, 2005, Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep, Bone, 37, 699, 10.1016/j.bone.2005.06.011

Kimura, 2000, BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6, J Biol Chem, 275, 17647, 10.1074/jbc.M908622199

Hay, 2001, Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway, J Biol Chem, 276, 29028, 10.1074/jbc.M011265200

Poynton, 2002, Safety profile for the clinical use of bone morphogenetic proteins in the spine, Spine, 27, S40, 10.1097/00007632-200208151-00010